Researchers from New York City-based organizations Columbia University and NewYork-Presbyterian have developed an AI tool capable of identifying patients at risk of having undiagnosed structural heart disease. The tool, called EchoNext, was trained on more than 1.2 million electrocardiogram and…
The Latest
Fort Lauderdale-based Holy Cross Health, part of Livonia, Mich.-based Trinity Health, is set to receive a $5 million gift to strengthen heart and vascular care. The planned gift is among the largest Holy Cross Health has received in its 70-year…
The American College of Cardiology has recognized more than 400 U.S. hospitals for their quality and consistency in meeting care guidelines for patients with acute myocardial infarction. To be eligible for a 2025 Performance Achievement Award, hospitals must be participants…
A team at Durham, N.C.-based Duke Health successfully developed and performed the world’s first on-table heart reanimation for a 3-month-old patient earlier this year. The new technique enables surgeons to temporarily reanimate a donor heart outside of the body with…
Fifteen U.S. hospitals have joined the American Heart Association’s newly established Hemorrhagic Stroke Surgical Quality Improvement Initiative. The hospitals will collaborate to identify, adopt and amplify a standardized care model for intracerebral hemorrhage across the U.S. The initiative receives financial…
Despite the volume of cardiovascular services performed in ASCs projected to grow 15% between 2023 and 2028, according to an article published July 7 in JACC, Medicare reimbursement for cardiovascular procedures varies across clinical settings. Here are the Medicare reimbursement…
In 2021, about 25% of all ASCs in the U.S. had hospital shareholders, according to an article published July 7 in JACC. With the volume of ASCs in the U.S. expected to grow 21% by 2034, researchers were interested in…
In a recent American College of Cardiology survey, 40% of cardiologists said they had not received any training in cardiogenetic testing, according to a study to be published in the forthcoming August 2025 issue of JACC: Advances. The ACC surveyed…
The FDA has given 510(k) clearance to health tech company Aktiia for over-the-counter use of its G0 Blood Pressure Monitoring system. According to the FDA website, the device received clearance July 2. The system, already available in Europe, is the…
Cleveland-based University Hospitals Harrington Heart & Vascular Institute has become the first site in Ohio to clinically administer Flyrcado for the detection of coronary artery disease and arterial blockages. Flyrcado is a first-of-its-kind advanced positron emission tomography-scan myocardial perfusion imaging…